J&J Has A Plan B If Gamechanger Single Dose Vaccine Disappoints

OWS Leader Predicts Success

 
• By Andrew McConaghie
  
J&J vaccine trial
J&J's single dose vaccine could be a gamechanger - but has to come close to the efficacy achieved by Moderna and Pfizer/BioNTech's products. • Source: Michael Ciaglo/Getty Images
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip